IndieBio Showcase Latest SynBio Startups
News Jul 28, 2016
The IndieBio EU programme is designed to support individuals and companies with an early stage prototype, investing in them with cash, laboratory space, technical and academic support in the School of Microbiology, and mentorship from top experts in industry, to develop them into viable companies.
Thirteen global startups, from North America, Canada, South America, Europe and Ireland, are currently located in Cork and working with the IndieBio team, SOSV and a global network of mentors and advisers to bring the companies from early stage concepts to investment ready companies.
According to Bill Liao, cofounder of IndieBio and European venture partner for SOSV, “IndieBio carefully selects teams from around the world who have the potential and the capacity to create world changing biotech solutions for problems that were previously seen as intractable. SOSV created IndieBio as a way to attract world class companies in the field of synthetic biology into Ireland and Cork.”
While synthetic biology exists at the intersection of science, technology and engineering, the IndieBio teams work closely with industry and academic partners such as UCC in Cork.
According to Liao, “the IndieBio accelerator programme is the first of its kind in the world in the field of life sciences and Cork was chosen for a very good reason. Ireland and Cork are extremely well resourced in the area of life sciences and key academic partners plus support from Enterprise Ireland in Cork gives startups a competitive advantage, he said.”
“Synthetic biology is helping scientists provide groundbreaking solutions to some of the most complex issues around the globe and technical advances now mean that many more projects are now possible due to reduction in the cost and time required to get concepts from the laboratory to the marketplace,” he added.
Scientists at McGill have found the answer to a question that perplexed Charles Darwin; if natural selection works at the level of the individual, fighting for survival and reproduction, how can a single colony produce worker ants that are so dramatically different in size – from “minor” workers to large-headed soldiers with huge mandibles – especially if they are sterile?
Scientists have developed a successful method to make truly personalized predictions of future disease outcomes for patients with certain types of chronic blood cancers. The study combined extensive genetic and clinical information to predict the prognosis for patients with myeloproliferative neoplasms.
For centuries, gardeners have attempted to breed blue roses with no success. But now, thanks to modern biotechnology, the elusive blue rose may finally be attainable. Researchers have found a way to express pigment-producing enzymes from bacteria in the petals of a white rose, tinting the flowers blue.
2nd International Conference on Computational Biology and Bioinformatics
May 17 - May 18, 2019
2nd World Congress on Genetics & Genetic Disorders
May 13 - May 14, 2019